Jackson Thornton Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Jackson Thornton Wealth Management's ABBV Position: Q3 2026 in Review
Jackson Thornton Wealth Management reduced its AbbVie (ABBV) stake by 35% in Q3 2026, selling an estimated $167K and leaving 1,222 shares worth $320K. The position accounts for 0.02% of the portfolio, ranked #232.
Jackson Thornton Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 12 quarters since. The position peaked at $472K in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Jackson Thornton Wealth Management held 1,222 shares of AbbVie worth $320K as of Q3 2026.
- Jackson Thornton Wealth Management sold 652 AbbVie shares in Q3 2026, an estimated $167K.
- AbbVie made up 0.02% of Jackson Thornton Wealth Management's portfolio in Q3 2026, its #232 holding.
- Jackson Thornton Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 12 quarters since.
- Jackson Thornton Wealth Management's AbbVie position peaked at $472K in Q2 2026.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Jackson Thornton Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.